ISCHEMIA
“Initial Invasive or Conservative Strategy for Stable Coronary Disease“ Maron DJ, Hochman JS, Reynolds HR, et al. for the ISCHEMIA
Continue readingAuthor: admin
Fecal Transplant for Clostridium Difficile
“Duodenal Infusion of Donor Feces for Recurrent Clostridium difficile” Els van Nood, M.D. et al. N Engl J Med. 2013
Continue readingACCORD
“Effects of Intensive Glucose Lowering in Type 2 Diabetes” by the Action to Control Cardiovascular Risk in Diabetes (ACCORD) Study
Continue readingTRISS
“Lower versus Higher Hemoglobin Threshold for Transfusion in Septic Shock“ Holst LB, Haase N, Wetterslev J, et al.; TRISS Trial
Continue readingVERT
“Effects of Risedronate Treatment on Vertebral and Nonvertebral Fractures in Women With Postmenopausal Osteoporosis” by Harris ST, Watts NB, Genant
Continue readingACTT-1 – Remdesivir
“Remdesivir for the Treatment of Covid-19 — Preliminary Report” J.H. Beigel, et al. and the ACTT-1 Study Group Members N
Continue readingAblation for Barrett’s Esophagus
“Radiofrequency Ablation in Barrett’s Esophagus with Dysplasia” Shaheen NJ, Sharma P, Overholt BF, et al. N Engl J Med. 2009;360(22):2277-2288.
Continue readingALMS
“Mycophenolate Mofetil versus Cyclophosphamide for Induction Treatment of Lupus Nephritis” by the Aspreva Lupus Management Study (ALMS) Group JASN May
Continue readingRAVE
“Rituximab versus Cyclophosphamide for ANCA-Associated Vasculitis” by the Rituximab in ANCA-Associated Vasculitis-Immune Tolerance Network (RAVE-ITN) Research Group N Engl J
Continue readingPARAGON-HF
“Angiotensin-Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction” N Engl J Med. 2019 Oct 24;381(17):1609-1620 [Full text] Summary by
Continue reading